[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-288933-105":53,"doc-detail-288933-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","provider-perspectives-on-specialty-prescribing-overview-data-and-provider-survey-findings","Provider Perspectives on Specialty Prescribing - Overview - Data and Provider Survey Findings","","Provider Perspectives on Specialty Prescribing explains how prescribing specialty medications is complex, time-consuming, and hindered by gaps in actionable information at the point of care. It outlines key challenges such as prior authorization complexity, patient enrollment burdens, limited digital access to prescription cost and coverage details, and low provider confidence in manually obtained information. Survey results describe provider pain points, administrative workload, delays to therapy, and demand for trustworthy cost and access data to improve prescribing efficiency.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/provider-perspectives-on-specialty-prescribing-overview-data-and-provider-survey-findings/288933/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/provider-perspectives-on-specialty-prescribing-overview-data-and-provider-survey-findings/288933.png","ImageObject",442,249,{"name":88,"@type":89},"Maya Linwood","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-11","2026-09-17",true,{"@type":98,"interactionType":99,"userInteractionCount":73},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"Why is specialty prescribing described as complex and time-consuming?","Question",{"text":108,"@type":109},"Specialty medications require unique handling and involve high-touch processes, especially around prior authorization and patient enrollment. The process is further complicated by gaps in key information and manual workflows.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What survey-identified pain points affect providers when writing specialty prescriptions?",{"text":113,"@type":109},"Providers report a lack of key information during drug selection and burdensome manual prescribing processes. They also indicate that better information at the point of care could address these problems.",{"name":115,"@type":106,"acceptedAnswer":116},"How do delays and administrative burden impact patients and providers?",{"text":117,"@type":109},"The document notes that it can take nearly 8 days on average to start patients on specialty medication and highlights that callbacks and additional paperwork may be required. Providers spend significant weekly time on non-clinical administrative tasks tied to prescribing.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},288933,1791741390,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":135,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":79,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":73},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","PROVIDER PERSPECTIVES  \nON SPECIALTY PRESCRIBING  \nPrescribing specialty medications is a complex and time-consuming process. Today there is no simple definition for specialty medications, but in general, they are costly and require unique handling. To manage the high costs and high-touch patient care associated with specialty medications, providers must follow specific guidelines for prior authorization and patient enrollment.  \nBranded specialty medications are projected to surpass half of medicine spending in [the U.S. by](the U.S. by)  \n[2022](2022).1 And specialty medication takes up 94% of commercial medical benefit drug spend, but this spend represents just 15% of all patients.2 Since costs often fall under the patient’s medical benefit—not the pharmacy benefit—the information gap that providers face widens.  \nIn 2018, Surescripts surveyed providers to gain insight on their experience when writing specialty prescriptions. We identified two pain points:  \na lack of key information in drug selection and the burdensome manual prescribing process.  \nProviders believe that the pain points can be addressed and specialty prescribing improved if they have the right information at the point of care.  \nTHE STATE OF SPECIALTY PRESCRIBING TODAY  \nSpecialty drugs are generally classified as high-cost medications used to treat complex, chronic conditions like cancer, rheumatoid arthritis and multiple sclerosis. As a result, providers face many challenges: Is the medication covered under the patient’s pharmacy benefit plan? Can the patient afford it? When will the medication arrive?  \nLESS THAN ONE-THIRD OF PROVIDERS (29%) are extremely or very satisfied with their organization’s efficiency when  \nprescribing specialty medication.3  \nNEARLY 40% OF PROVIDERS  \nsay it can take from one to two weeks to get their patients on a  \nspecialty medication.4  \nWhen physicians encounter barriers to prescribing, roughly TWO-THIRDS (67%) change or reroute  \ntheir orders.5  \nDelayed time to therapy and high drug costs hamper providers’ efforts to deliver effective treatment. On average, providers report it can take nearly 8 days to start patients on specialty medication.6 More than half of specialty drugs exceed $100,0007 annually and spending on branded specialty drugs is rising 10% year over year.8 This drives provider demand for complete, trustworthy information that includes prescription costs at the point of care.  \nREAL-WORLD PATIENT EXPERIENCE:  \nFor example, take a patient who suffers from plaque psoriasis, which covers 20% of her body. She tries a generic oral medication but it is not effective. Her provider suggests that she try a brand name injectable biologic drug instead, but the lack of key prescription information and the manual process causes confusion and delay. First, the provider spends precious non-clinical time coordinating the prior authorization—and misses crucial information as a result of the manual process. This requires callbacks and additional paperwork to resolve. And the question of coverage under the patient’s benefit plan (the medication costs more than $30,000 per year) requires yet more back-and-forth time and effort with benefit plan administrators. In all, it takes 10 days to get the medication into the patient’s hands.  \nPROVIDERS DON’T HAVE DIGITAL ACCESS TO PRESCRIPTION INFORMATION & DON’T TRUST THE INFORMATION 9  \nPROVIDERS DON’T HAVE DIGITAL ACCESS TO INFORMATION  \nPROVIDERS DON’T TRUST  \nINFORMATION OBTAINED MANUALLY  \n\n| \u003Cbr>87% | patient out-of-pocket cost | \u003Cbr>67% |\n| --- | --- | --- |\n| \u003Cbr>77% | availability of lower cost alternatives | \u003Cbr>76% |\n| \u003Cbr>80% | prior authorization requirements | \u003Cbr>58% |\n| \u003Cbr>76% | specialty pharmacy locations | \u003Cbr>57% |\n\n02 I PROVIDER PERSPECTIVES ON SPECIALTY PRESCRIBING  \nPROVIDERS SPEND VALUABLE TIME*  \nON ADMINISTRATIVE & NON-CLINICAL TASKS 10  \n*Average amount of time providers spend per week on various tasks associated with the prescribing process, as represente","cbCaigG3wgb4IPi2","https://ap.wps.com/l/cbCaigG3wgb4IPi2","pdf",1054733,8,"English","# Provider Perspectives on Specialty Prescribing\n## Specialty medications: complexity and lack of clear definition\n## The state of specialty prescribing today\n## Real-world patient experience and resulting delays\n## Provider pain points: digital access and trust in information\n## Time spent on administrative and non-clinical tasks\n## What providers believe improves prescribing","[{\"question\":\"Why is specialty prescribing described as complex and time-consuming?\",\"answer\":\"Specialty medications require unique handling and involve high-touch processes, especially around prior authorization and patient enrollment. The process is further complicated by gaps in key information and manual workflows.\"},{\"question\":\"What survey-identified pain points affect providers when writing specialty prescriptions?\",\"answer\":\"Providers report a lack of key information during drug selection and burdensome manual prescribing processes. They also indicate that better information at the point of care could address these problems.\"},{\"question\":\"How do delays and administrative burden impact patients and providers?\",\"answer\":\"The document notes that it can take nearly 8 days on average to start patients on specialty medication and highlights that callbacks and additional paperwork may be required. Providers spend significant weekly time on non-clinical administrative tasks tied to prescribing.\"}]","Provider Perspectives on Specialty Prescribing - Overview - Data and Provider Survey Findings | PDF",1789634243]